| Jennifer Suzanne Wellman, RN | |
|
316 Fox Hollow Dr, Hudson, NH 03051-4858 | |
| (978) 853-0619 | |
| Not Available |
| Full Name | Jennifer Suzanne Wellman |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 316 Fox Hollow Dr, Hudson, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427299734 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 270713 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Suzanne Wellman, RN 316 Fox Hollow Dr, Hudson, NH 03051-4858 Ph: (978) 853-0619 | Jennifer Suzanne Wellman, RN 316 Fox Hollow Dr, Hudson, NH 03051-4858 Ph: (978) 853-0619 |
News Archive
Plexxikon Inc. today announced encouraging clinical data from a Phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase of the study. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors.
Results from a new survey from the American Heart Association/American Stroke Association found that only half of healthcare professionals consider themselves to be adequately equipped with information about cryptogenic stroke, a stroke in which the underlying cause is still unknown after extensive testing.
Dr. Jeffrey L. Saver, professor of neurology at the David Geffen School of Medicine at UCLA and director of the UCLA Stroke Center, received the William Feinberg Award for Excellence in Clinical Stroke at the American Stroke Association's 2012 International Stroke Conference in New Orleans on Feb. 2.
Laboratory Corporation of America® Holdings announced today the nationwide availability of a genetic test to detect the presence of a single polymorphism within the IL-28B gene that has been reported to help predict a person's response to certain hepatitis C virus (HCV) therapies.
Precision BioSciences and Agrivida revealed today that they have entered into a trait development collaboration based on precise gene modifications made possible by Precision's Directed Nuclease Editor (DNE) Technology.
› Verified 5 days ago
Sheila Regan, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4 Tessier Street, Hudson, NH 03051 Phone: 603-880-0641 | |
Ashley Therese Shannak, RN Registered Nurse Medicare: Medicare Enrolled Practice Location: 208 Robinson Rd, Hudson, NH 03051 Phone: 603-882-6700 | |
Ms. Meagan Dembitzky, RN, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 142 Lowell Rd Unit 17-151, Hudson, NH 03051 Phone: 978-233-1594 Fax: 949-561-4522 | |
Emily Cambra, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Heritage Cir, Hudson, NH 03051 Phone: 603-560-8886 | |
Donna Boucher, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 323 Derry Rd, Hudson, NH 03051 Phone: 603-595-3399 | |
Michelle Arseneault, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 712 Elmwood Dr, Hudson, NH 03051 Phone: 603-234-3861 |